NCT07475806
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07475806
Title A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arkansas Urology Associates RECRUITING Little Rock Arkansas 72211 United States Details
University of Illinois College of Medicine - UIC Cancer Center RECRUITING Chicago Illinois 60612 United States Details
Accellacare of Duly RECRUITING Lisle Illinois 60532 United States Details
NYU Langone Urology Associates RECRUITING New York New York 10017 United States Details
Centers for Advanced Urology, LLP RECRUITING Bala-Cynwyd Pennsylvania 19004 United States Details
Thomas Jefferson University RECRUITING Philadelphia Pennsylvania 19107 United States Details
Sidney Kimmel Comprehensive Cancer - Asplundh Cancer Pavilion RECRUITING Willow Grove Pennsylvania 19090 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Urology San Antonio RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field